Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: Localization to the T-B interface of the splenic follicle

Journal of Experimental Medicine

Volumn 186, Issue 8, 1997, Pages 1257-1267

  Mandik Nayak, Laura ^a   Bui, Anh ^a   Noorchashm, Hooman ^a   Eaton, Ashlyn ^a   Erikson, Jan ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYBRIDOMA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSGENE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CELL SURVIVAL; DNA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COOPERATION; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; SPLEEN; T-LYMPHOCYTES;

EID: 0030827382     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.8.1257     Document Type: Article

References (60)

1. Nemazee, D.A., and K. Bürki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature (Lond.). 337:562-566.
2. Hartley, S.B., J. Crosbie, R. Brink, A.B. Kantor, A. Basten, and C.C. Goodnow. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature (Lond.). 353:765-769.
3. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J. Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wothersponn, R.H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature (Lond.). 334:676-682.
4. Fulcher, D.A., and A. Basten. 1994. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J. Exp. Med. 179:125-134.
5. Hertz, M., and D. Nemazzee. 1997. BCR ligation induces receptor editing in IgM+IgD-bone marrow B cells in vitro. Immunity. 6:429-136.
6. Chen, C., E.L. Prak, and M. Weigert. 1997. Editing disease-associated autoantibodies. Immunity. 6:97-105.
7. Theofilopoulos, A.N., and F.J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269-390.
8. Shlomchik, M., M. Mascelli, H. Shan, M.Z. Radic, D. Pisetsky, A. Marshak-Rothstein, and M. Weigert. 1990. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171:265-297.
9. Radic, M.Z., M.A. Mascelli, J. Erikson, H. Shan, and M. Weigert. 1991. Ig H and L chain contributions to autoimmune specificities. J. Immunol. 146:176-182.
10. Roark, J.H., C.L. Kuntz, K.-A. Nguyen, A.J. Caton, and J. Erikson. 1995. Breakdown of B cell tolerance in a mouse model of SLE. J. Exp. Med. 181:1157-1167.
11. Ibrahim, S.M., M. Weigert, C. Basu, J. Erikson, and M.Z. Radic. 1995. Light chain contribution to specificity in anti-DNA antibodies. J. Immunol 155:3223-3233.
12. Cyster, J.G., S.B. Hartley, and C.C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature (Lond.). 371:389-395.
13. Cyster, J.G., and C.C. Goodnow. 1995. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity. 3:691-701.
14. Chen, C., Z. Nagy, M.Z. Radic, R.R. Hardy, D. Huszar, S.A. Camper, and M. Weigert. 1995. The site and stage of anti-DNA B cell deletion. Nature (Lond.). 373:252-255.
15. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177:999-1008.
16. Iliev, A., L. Spatz, S. Ray, and B. Diamond. 1994. Lack of allelic exclusion permits autoreactive B cells to escape deletion. J. Immunol. 153:3551-3556.
17. Tsao, B.P., A. Chow, H. Cheroutre, Y.W. Song, M.E. McGrath, and M. Kroneberg. 1993. B cells are anergic in transgenic mice that express IgM anti-DNA antibodies. Eur. J. Immunol. 23:2332-2339.
18. Hagman, J., D. Lo, L.T. Doglio, J.J. Hackett, C.M. Rudin, D. Haasch, R. Brinster, and U. Storb. 1989. Inhibition of immunoglobulin gene rearrangement by the expression of a λ2 transgene. J. Exp. Med. 169:1911-1929.
19. Tiegs, S.L., D.M. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009-1020.
20. Spatz, L., V. Saenko, A. Iliev, L. Jones, L. Geskin, and B. Diamond. 1997. Light chain usage in anti-double stranded DNA B cell subsets: role in cell fate determination. J. Exp. Med. 185:1317-1326.
21. Tan, E.M., E.K.L. Chan, K.F. Sullivan, and R.L. Rubin. 1988. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin. Immunol. Immunopathol. 47:121-141.
22. Condemi, J.J. 1992. The autoimmune diseases. JAMA (J. Am. Med. Assoc.). 268:2882-2892.
23. Erikson, J., M.Z. Radic, S.A. Camper, R.R. Hardy, C. Carmack, and M. Weigert. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature (Lond.). 349:331-334.
24. Radic, M.Z., J. Erikson, S. Litwin, and M. Weigert. 1993. B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177:1165-1173.
25. Hardy, R.R., C.E. Carmack, S.A. Shinton, J.D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of proB and pre-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213-1225.
26. Allman, D.M., S.E. Ferguson, V.M. Lentz, and M.P. Cancro. 1993. Peripheral B cell maturation. II. Heat-stable antigen hi splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Imnnmol. 151:4431-4444.
27. Jacob, J., R. Kassir, and G. Kelsoe. 1991. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J. Exp. Med. 173:1165-1175.
28. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209-1213.
29. Stark, S., and A.J. Caton. 1991. Antibodies that are specific for a single amino acid interchange in a protein epitope use structurally distinct variable regions. J. Exp. Med. 174:613-624.
30. Roark, J.H., C.L. Kuntz, K.-A. Nguyen, L. Mandik, M. Cattermole, and J. Erikson. 1995. B cell selection and allelic exclusion of an anti-DNA immunoglobulin transgene in MRL-lpr/lpr mice. J. Immunol. 154:4444-4455.
31. Cooke, M.P., A.W. Heath, K.M. Shokat, Y. Zeng, F.D. Finkelman, P.S. Linsley, M. Howard, and C.C. Goodnow. 1994. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179:425-438.
32. Hartley, S.B., M.P. Cooke, D.A. Fulcher, A.W. Harris, S. Cory, A. Basten, and C.C. Goodnow. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death. Cell. 72:325-335.
33. Prak, E.L., M. Trounstine, D. Huszar, and M. Weigert. 1994. Light chain editing in κ-deficient animals: a potential mechanism of B cell tolerance. J. Exp. Med. 180:1805-1815.
34. Chen, C., M.Z. Radic, J. Erikson, S.A. Camper, S. Litwin, R.R. Hardy, and M. Weigert. 1994. Deletion and editing of B cells that express antibodies to DNA. J. Immunol. 152: 1970-1982.
35. Hang, L., A.N. Theofilopoulos, R.S. Balderas, S.J. Francis, and F.J. Dixon. 1984. The effect of thymectomy on lupusprone mice. J. Immunol. 132:1809-1813.
36. Jabs, D.A., C.L. Burek, Q. Hu, R.C. Kuppers, B. Lee, and R.A. Pendergast. 1992. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell. Immunol. 141:496-507.
37. Wofsy, D., J.A. Ledbetter, P.L. Hendler, and W.E. Seaman. 1985. Treatment of murine lupus with monoclonal anti-T cell antibody. J. Immunol. 134:852-857.
38. Nitschke, L., R. Carsetti, B. Ocker, G. Kohler, and M. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7:133-143.
39. Molina, H., T. Kinoshita, K. Inque, J.-C. Carel, and V.M. Holers. 1990. A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145:2974-2983.
40. Dorken, B., G. Moldenhauer, A. Pezzutto, R. Schwartz, A. Feller, S. Kiesel, and L.M. Nadler. 1986. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J. Immunol. 136:4470-4479.
41. Kikutani, H., M. Suemura, H. Owaki, H. Nakamura, R. Sato, K. Yamasaki, E. Barsumian, R. Hardy, and T. Kishimoto. 1986. Fc∈ receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J. Exp. Med. 164:1455-1469.
42. Ahearn, J.M., M.B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R.G. Howard, T.L. Rothstein, and M.C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction of B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity. 4:251-262.
43. O'Keefe, T.L., G.T. Williams, S.L. Davies, and M.S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science (Wash. DC). 274:798-801.
44. Sato, S., A.S. Miller, M. Inaoki, C.B. Bock, P.J. Jansen, M.L.K. Tang, and T.F. Tedder. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity. 5:551-562.
45. Fearon, D.T., and R.H. Carter. 1995. The CD19/CR2/ TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127-149.
46. Nadler, L.M., K.C. Anderson, G. Marti, M. Bates, E. Park, J.F. Daley, and S.F. Schlossman. 1983. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J. Immunol. 131:244-250.
47. Camp, R.L., T.A. Kraus, M.L. Birkeland, and E. Pure. 1991. High levels of CD44 expression distinguish virgin from antigen-primed B cells. J. Exp. Med. 173:763-766.
48. Hathcock, K.S., H. Hirano, S. Murakami, and R.J. Hodes. 1993. CD44 expression on activated B cells: differential capacity for CD44-dependent binding to hyaluronic acid. J. Immunol. 151:6712-6722.
49. Roehm, N.W., H.J. Leibson, A. Zlotnik, J. Kappler, P. Marrack, and J.C. Cambier. 1984. Interleukin-induced increase in Ia expression by normal mouse B cells. J. Exp. Med. 160: 679-694.
50. Mobley, J.L., and M.O. Dailey. 1992. Regulation of adhesion molecule expression by CD8 T cells in vivo. I. Differential regulation of gp90MEL-14, Pgp-1, LRA-1, and VLA-4α during the differentiation of cytotoxic T lymphocytes induced by allogratts J. Immunol. 148:2348-2356.
51. Gallatin, W.M., I.L. Weissman, and E.C. Butcher. 1983. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature (Lond.). 304:30-34.
52. Chan, E.Y.T., and I.C.M. MacLennan. 1993. Only a small proportion of splenic B cells in adults are short-lived virgin cells. Eur. J. Immunol. 23:357-363.
53. Roark, J.H., A. Bui, K.-A. Nguyen, L. Mandik, and J. Erikson. 1997. Persistence of functionally compromised anti-dsDNA B cells in the periphery of non-autoimmune mice. Int. Immunol. In press.
54. Fulcher, D.A., A.B. Lyons, S.L. Korn, M.C. Cooke, C. Koleda, C. Parish, B. Fazekas de St. Groth, and A. Basten. 1996. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183:2313-2328.
55. Cyster, J. 1997. Signaling thresholds and interclonal competition in preimmune B-cell selection. Immunol. Rev. 156:87-101.
56. Jacobson, B.A., T.L. Rothstein, and A. Marshak-Rothstein. 1997. Unique site of IgG2a and rheumatoid factor production in MRL/1pr mice, Immunol. Rev. 156:103-110.
57. Jacobson, B.A., D.J. Panka, K.-A.T. Nguyen, J. Erikson, A.K. Abbas, and A. Marshak-Rothstein. 1995. Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity. 3:509-519.
58. Rathmell, J.C., M.P. Cooke, W.Y. Ho, J. Grein, S.E. Townsend, M.M. Davis, and C.C. Goodnow. 1995. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature (Lond.). 376:181-184.
59. Rothstein, T.L., J.K.M. Wang, D.J. Panka, L.C. Foote, Z. Wang, B. Stanger, H. Cui, S.-T. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature (Lond.). 374:163-165.
60. Osmond, D.G. 1986. Population dynamics of bone marrow B lymphocytes. Immunol. Rev. 93:103-124.